Find your path to Patrick
322 people in our graph share verified history with Patrick — schools, employers, funds. One of them is your warm intro.
Paul FieldingunlockedPatrick: together at UCLA (2004–2005)
×5Patrick: together at University of California, Berkeley, Haas School of Business
×4Patrick: together at UCLA
Patrick: together at Plexium
About
Patrick Rivers is a Portfolio Manager for aMoon Edge, overseeing the fund's public healthcare investments and leading private therapeutics investments for aMoon Growth. Before joining aMoon in August 2024, he was Managing Director and Head of Research at Aquilo Capital Management, a biotechnology-focused investment fund concentrating on small- and mid-cap public therapeutics companies. He earlier worked as a bench scientist in drug development at Xoma, Exelixis, and Sutro Biopharma, and holds an MBA from UC Berkeley's Haas School of Business and a BS in Chemical Engineering from UCLA.
Invests in
BiotechHealthtech
Board director at Plexium
Intro paths
→
In turn, Patrick can intro founders to Plexium's investors below.
Plexium's investors · 8
CRV (Charles River Ventures)Bay Area · $250K – $5M checks · since 2025DCVC (Data Collective)Palo Alto · $5M – $25M checks · since 2025M VenturesLos Angeles · $10.8M checks · since 2025Neotribe VenturesMenlo Park · $250K – $2M checks · since 2025Pivotal Life SciencesSan Francisco · since 2025SoftBank Vision FundLondon · since 2025TCG CrossoverPalo Alto · since 2025The Column GroupSan Francisco · $30M checks · since 2025
Experience
- aMoon FundPortfolio Managercurrent2024 — presentBoston, Massachusetts, United States
- ISCT, International Society for Cell & Gene TherapyCo-Chair, Business Development and Finance Committeecurrent2018 — present
- Aquilo Capital ManagementManaging Director / Head of Research2014 — 2024San Francisco
- Sutro Biopharma, Inc.Senior Research Associate2011 — 2014
- ExelixisAssociate Research Scientist2009 — 2011
- XOMAProcess Development Assoc. II2005 — 2009
Skills & more
Fermentation13Antibodies14Cell Culture8Molecular Biology9Protein Expression10Technology Transfer5ELISA4Western Blotting1SDS-PAGE2HPLC3Assay Development10Protein Purification7
+4 more
BiotechnologyPurificationHigh Throughput ScreeningDrug DiscoveryFrom Patrick's professional profile.
Colleagues at aMoon
Frequently asked questions
- Who is Patrick Rivers?
- Patrick Rivers is a Portfolio Manager for aMoon Edge, overseeing the fund's public healthcare investments and leading private therapeutics investments for aMoon Growth. Before joining aMoon in August 2024, he was Managing Director and Head of Research at Aquilo Capital Management, a biotechnology-focused investment fund concentrating on small- and mid-cap public therapeutics companies. He earlier worked as a bench scientist in drug development at Xoma, Exelixis, and Sutro Biopharma, and holds an MBA from UC Berkeley's Haas School of Business and a BS in Chemical Engineering from UCLA.
- Where does Patrick Rivers work?
- Patrick Rivers is Portfolio Manager, aMoon Edge at aMoon and Board director at Plexium.
- What does Patrick Rivers invest in?
- Patrick Rivers invests in Biotech, Healthtech.
- Where did Patrick Rivers go to school?
- Patrick Rivers studied at University of California, Berkeley, Haas School of Business (Master of Business Administration (MBA)); UCLA (BS, Chemical Engineering).
Same school
Also attended University of California, Berkeley, Haas School of Business885
Mark FiorentinoInvestor at Index VenturesRishi ModiInvestor at GV (Google Ventures)Yibo NianInvestment Director at Intel CapitalZhenyu TangInvestment Director at Intel CapitalDennisDirector of Trading at Pantera CapitalAnna ChenInvestor at Madrona Venture Group
+ 879 more
Also attended UCLA903
Ben HorowitzCo-founder & General Partner at Andreessen HorowitzKirsten GreenFounder and Managing Partner at Forerunner VenturesVlad TenevCo-founder & CEO of RobinhoodRyan KingCo-founder of ChimePaul FieldingFinance & Operations at General CatalystMelody MaExecutive Assistant and Lead Receptionist at Trinity Ventures
+ 897 more
Shared employers
Also worked at ISCT, International Society for Cell & Gene Therapy3
Also worked at Sutro Biopharma, Inc.5
Also worked at Exelixis15
Richard HeymanVenture Partner at ARCH Venture PartnersVincent HsiehManaging Director at Cypress Growth CapitalAngie YouSenior Advisor at Frazier Life SciencesTom HeymanExecutive Partner at Bioqube VenturesJen HerbachFounder at Adventris PharmaceuticalsMark Taegon BaikFounder at Arum Therapeutics
+ 9 more
